- TREATMENT OF TARDIVE SYNDROMES
TREATMENT OF TARDIVE SYNDROMES This is a summary of the American Academy of Neurology (AAN) guideline regarding management of tardive syndromes (TDS), including tardive dyskinesias (TDD)
- Tardive Dyskinesia Guidelines: Guidelines Summary - Medscape
American Academy of Neurology (AAN) The American Academy of Neurology (AAN) guidelines for the treatment of tardive dyskinesia (TD) provide evidence-based recommendations for the diagnosis and management of this condition [31] The AAN guidelines emphasize the importance of early recognition, regular monitoring, and a tailored approach to the management of TD, balancing the need for
- Treatment Recommendations for Tardive Dyskinesia - PMC
Tardive dyskinesia is a movement disorder characterised by irregular, stereotyped, and choreiform movements associated with the use of antipsychotic medication We aim to provide recommendations on the treatment of tardive dyskinesia We performed a
- Evidence-based guideline: Treatment of tardive syndromes
This guideline provides evidence-based recommendations for the treatment of tardive syndromes, focusing on effective management strategies and therapeutic interventions
- Tardive Dyskinesia (TD) Treatment Guidelines
TD, tardive dyskinesia; VMAT2, vesicular monoamine transporter 2 * Level A is the strongest recommendation, established as effective, based on at least 2 consistent class I studies Level B refers to probably effective treatment, derived from at least 1 class I study or 2 consistent class II studies
|